Rabivax S – Serum International Institute
Indication and Usage –
Dosage and Administration –
The following schedule should be followed for pre-exposure prophylaxis in high risk populations.
Route |
Dose |
Number of doses |
Schedule |
Intramuscular |
1 ml |
3 |
Day 0, 7 and 21 or 28 |
Intradermal |
0.1 ml |
3 |
Day 0, 7 and 21 or 28 |
In order to remove as much of the rabies virus as possible, immediately cleanse the wound with soap and wash thoroughly with water.
The following schedule should be followed for post-exposure prophylaxis in previously unimmunized populations.
Route |
Dose |
Number of doses |
Schedule |
Intramuscular |
1 ml |
5 |
Day 0, 3, 7, 14 and 28 |
Intradermal |
0.1 ml + 0.1 ml |
4 |
Day 0, 3, 7 and 28 |
Contraindications –
In case of fever or an acute illness, vaccination should be postponed. In case of previous severe reaction to any components of the vaccine, Rabivax-S is contraindicated. In all cases, the risk/benefit ratio should be assessed.
Because of the life threatening risk of rabies, there are no contraindication to the administration of Post-exposure prophylaxis using Rabivax-S. The intradermal route must not be used in the individuals receiving long term corticosteroid or other immunosuppressive therapy or chloroquine for malaria treatment or prophylaxis and in immunocompromised individuals. Such individuals may have a reduced response to intradermal rabies vaccination and should instead receive the vaccine intramuscularly.
Adverse reactions –
Drug interactions and other interactions –
The recommended dose of rabies Immunoglobulin should not exceed nor should repeated doses of the same be administered once the vaccination course has been started since a higher dose could interfere with the immune response to rabies vaccine.
Your email address will not be published. Required fields are marked *